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Abstract: Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy
(TSE) that affects members of the cervidae family. The infectious agent is a misfolded
isoform (PrPSC) of the host prion protein (PrPC). The replication of PrPSC initiates a cascade
of developmental changes that spread from cell to cell, individual to individual, and that for
some TSEs, has crossed the species barrier. CWD can be transmitted horizontally and
vertically, and it is the only TSE that affects free-ranging wildlife. While other TSEs are
under control and even declining, infection rates of CWD continue to grow and the disease
distribution continues to expand in North America and around the world. Since the ﬁrst
reported case in 1967, CWD has spread infecting captive and free-ranging cervids in 26
states in the US, 3 Canadian provinces, 3 European countries and has been found in captive
cervids in South Korea. CWD causes considerable ecologic, economic and sociologic
impact, as this is a 100% fatal highly contagious infectious disease, with no treatment or
cure available. Because some TSEs have crossed the species barrier, the zoonotic potential of
CWD is a concern for human health and continues to be investigated. Here we review the
characteristics of the CWD prion protein, mechanisms of transmission and the role of
genetics. We discuss the characteristics that contribute to prevalence and distribution. We
also discuss the impact of CWD and review the management strategies that have been used
to prevent and control the spread of CWD.
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Introduction
Background
Chronic wasting disease (CWD) is the prion disease of the cervidae family.1 Prion
diseases—or transmissible spongiform encephalopathies (TSEs)—are a group of
progressive neurodegenerative disorders that affect animals and humans. The ﬁrst
TSE was discovered in the 18th century; at the time it was a strange disease that
affected sheep, causing behavioral changes inducing excessive licking, scratching
and altered gait.2 After Scrapie was ﬁrst described in 1732, other diseases with
similar neurological characteristic, such as Creutzfeldt-Jakob disease in 1920
(CJD)3,4 and Kuru5 in 1957 were identiﬁed in humans.
The agent causing these diseases was not clearly deﬁned but was presumed to be a
viral infection of the central nervous system.6–9 By the year 1959, researchers had
linked Scrapie, Kuru and CJD by suggesting that they were related neuropathies.10,11
Eight more years passed before researchers considered that Scrapie was caused by a
proteinase agent.12–14 By the same year, 1967, a new disease named CWD was
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discovered in a farmed mule deer (Odocoileus hemionus
hemionus) in Colorado and later in mule deer and black-
tailed deer (Odocoileus hemionus columbianus) in
Colorado and Wyoming, USA;1 yet, the term TSE was far
from being used as a disease category.2
It was not until 1982 when Prusiner used the term
“prion”—derived from the words proteinaceous and infec-
tious—to describe the causative infectious agent of
Scrapie.15 The same year Prusiner and collaborators
proved that the causative agent of Scrapie was a protein.
In 1997, Prusiner and collaborators won the Nobel Prize
for the discovery of “Prions – a new biological principle of
infection” and for their contribution on prion research
development. While the consensus is that prion proteins
(denoted PrPSC from Scrapie) are the causative agents of
prion diseases, and further evidence support that PRNP—a
host gene that regulates the expression of the prion protein
PrPC—plays a crucial role in the development of TSEs,16
some researchers proposed bacterias17,18 and viruses19 as
causative agents of TSEs. However, these theories were
soon dismissed.20–22
Even though the characteristics of the TSEs disease
group are clear (Figure 1), they may present as inherited,
infectious or sporadic disorders in a variety of hosts
depending on the TSE (Table 1).23,24 Most TSEs are
under control or declining. However, CWD is on the rise
and is the only prion disease of wild free-ranging animals;25
CWD continues to affect several cervidae host species
across the world. This review will introduce the unique
characteristics of CWD and the inﬂuence of genetics. We
will focus on prevalence and distribution, and examine the
impact of CWD and suggested management strategies.
CWD Characteristics
Prion proteins (PrPC) are cell-surface glycoproteins with
predominantly α-helical conformations. PrPC is encoded
by the prion protein gene (PRNP), which is present in
almost, if not all, mammalian species. The PrPC are
expressed in several tissues and cell types,26 including
epithelial, endothelial and immune cells.27–30 Above all,
PrPC is highly expressed in neurons and neuroglial cells
of the peripheral nervous system (PNS) and central nervous
system (CNS).31,32 The infectious prion protein is the mis-
folded isoform (PrPSC) of the cellular PrPC. The posttran-
slational process that causes conformational changes from a
predominantly α-helical isoform and a coil structure to a
refolded β-pleated sheet33 confers resistance to proteases
(eg, environmental, intestinal and intracellular) that would
Figure 1 Characteristics of transmissible spongiform encephalopathies (TSEs) or prion diseases.
Notes: Conformational changes of the host prion protein structure, from α-helices in the normal cell-surface glycoprotein (PrPC) to β-sheets in the misfolded isoform
(PrPSC). Data from Doherr (2007),23 Prusiner (1998),26 Novakofski et al (2005),34 Image credit to Kerry L. Helms, Scientiﬁc Illustrator (Public domain).159
Abbreviations: PrPC, the host prion protein; PrPSC, the misfolded isoform of the host prion protein.
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otherwise destroy the protein.34 Besides resistance, the β-
sheet structure of the pathogenic PrPSC is prone to aggrega-
tion. Aggregation of PrPSC leads to the conversion of more
PrPC to PrPSC, formation of amyloid plaques and vacuoli-
zation that cause progressive neurodegeneration.35 Because
the modiﬁcation from PrPC to PrPSC is posttranslational, the
amino acid sequence of both, PrPC and PrPSC (209 resi-
dues), is identical within an individual.24 Hence, there is not
a substantial immune response and inﬂammatory reaction to
the infection.36,37 However, chronic inﬂammation may con-
tribute to natural CWD transmission, as chronic inﬂamma-
tion may upregulate cytokines enabling PrPSC accumulation
and propagation to other tissues.34 For example, follicular
dendritic cells and mast cells express high levels of
PrPC.28,36 Expression and release of PrPC from migratory
cells, such as mast cells, may facilitate quick progress of the
infectious prion from lymphoid tissues associated with the
gastrointestinal track to the PNS, CNS and brain.28
Prions are infectious pathogens that, in the case of
CWD, can be transmitted horizontally or vertically.
Horizontal transmission is the most effective CWD trans-
mission method, with reported incidence of disease in
captive mule deer of 89%,38 and early infection detected
in lymphoid tissue along the oral and digestive system 42
days post-oral inoculation in mule deer fawns.39
Horizontal transmission includes direct contact of an
infected and susceptible animal or contact of susceptible
animals with infected saliva, feces and urine. Indirect
horizontal transmission involves environmental compo-
nents and includes oral infection by ingestion of contami-
nated grass and/or soil during grazing and dust inhalation
of infectious particles bound to soil.40,41 Based on social
networks and contact patterns among free-ranging white-
tailed deer (Odocoileus virginianus), direct contact is the
primary contributor of CWD transmission among deer.42
Scientists considered vertical transmission (in utero)
an unexpected or rare process. Researchers believed
that high neonatal mortality in deer and elk populations
coupled with the solitary nature of cervids during par-
turition reduced the importance of maternal transmis-
sion in sustaining CWD.43 However, TSEs vertical
transmission has been conﬁrmed in sheep, cattle, felids,
humans and in transgenic mouse models.44–47 Recent
studies based on experimental models of CWD demon-
strated the transmission of CWD from doe (clinical and
sub-clinical mothers) to fawns (full-term viable, full-
term non-viable and in utero harvested offspring).48
These studies found 80% of the fetuses from CWD-
positive muntjac deer dams PrPSC positive, suggesting
previous underestimation of the transmission from
mother to offspring for all TSEs.48 Vertical transmis-
sion contributes to CWD infection in naturally exposed
elk populations.49
The development of clinical CWD can take months to
years. The incubation time—the period between exposure to
the pathogenic CWD prion to the development of clinical
signs and symptoms—in both, naturally and experimentally
infected cervids may vary from 2 to 4 years.43 Differences
in incubation periods could relate to infectious dose, route
of exposure, cervid species and/or genotype. For example,
incubation periods in orally inoculated mule deer ranged
from 3 months to 2 years, with differences in CNS accu-
mulation timing associated to genotype proﬁles.50 Similar
ﬁndings were reported for other cervid species; CWD-posi-
tive muntjac deer developed terminal disease in 18–24
months post-oral inoculation.69 Interestingly, viable off-
springs from those CWD-positive muntjac dams surpassed
the time usually seen for terminal disease in cervid species
(18–24 months).48 Although the maximum incubation per-
iod in free-ranging cervids is unknown, most CWD cases
have been reported in 3- to 7-year-old animals,43,51 which is
similar to the age groups of captive elk and mule deer that
succumb to CWD.1 Because the way prions spread through-
out the body, pathological changes and distribution of PrPSC
might be ﬁrst identiﬁed in the lymphoreticular system and
later in the CNS, similar to what has been described for
sheep infected with scrapie.52 Retropharyngeal lymph node
(RLN) and medulla oblongata at the level of the obex are
early sites of PrPSC accumulation50 and considered gold
standard tissues for postmortem CWD detection using
immunohistochemistry (IHC). Peripheral accumulation and
the excretion of the infective prion protein have been
thought to occur only after central nervous system replica-
tion and was associated with the time of clinical disease
manifestation.53 However, recent ﬁndings identiﬁed shed-
ding in excreta concurrent with peripheral lymphoid
accumulation.54 Newer antemortem detection methods
such as serial protein misfolding cyclic ampliﬁcation
(sPMCA) and real-time quaking-induced conversion (RT-
QuIC) are emerging as potential tools to detect low levels of
PrPSC in excreta and identify early accumulation of PrPSC
in peripheral tissue of sub-clinical CWD cases.49,55
A slow wasting process that leads to death charac-
terizes CWD. Clinical signs—objective evidence of dis-
ease—include polydipsia and polyuria (excessive thirst or
urination), sialorrhea (drooling or excessive salivation)
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and wasting (drastic weight loss). Behavioral changes
include listlessness, aggression, lack of fear of people
and depression.53 Signs of neurological damage at later
stages are characterized by a lack of coordination, difﬁ-
culty moving and ataxia (losing balance while walking).
Other distinctive characteristics associated with CWD are
drooping head and ears. The development of signs and
symptoms—subjective evidence of disease—is progres-
sive, with some of them such as polyuria and sialorrhea,
appearing at later stages of disease and contributing to the
shedding of the pathogenic PrPSC. Diagnosis based on
clinical signs and behavioral changes is not possible, as
these can be characteristics of other diseases.
Genetics
Eliminating or controlling the spread of TSEs has relied
heavily on a solid understanding of the molecular mechan-
isms of the disease. Earlier work demonstrated that a
pathogenic prion protein (PrPSc) is responsible for post-
translational conversion of the host encoded cellular prion
protein (PrPC) in several TSEs.16,24,56 The PRNP gene
which encodes the PrP protein is well conserved among
mammals,57 including cervids, and has implications for
CWD.58 Though other loci were examined for their invol-
vement (such as “Sinc”59 and Pid-160), variations in the
prion protein (PRNP) gene have been shown to affect TSE
progression61 and susceptibility.62–64 Due to this associa-
tion, much of the research on the genetics of CWD has
focused on this locus within affected cervids.
Complete genetic resistance has not yet been found for
cervids, though examination of PRNP sequences has identi-
ﬁed variable sites that may inﬂuence an individual animal’s
susceptibility to or the rate of progression of CWD. The
inferred amino acid sequence was described in Rocky
Mountain elk (Cervus elaphus nelsoni), ﬁnding only a single
mutation of methionine (M) to leucine (L) at cervid codon
132 with elk homozygous (M/M) overrepresented among
those infected with CWD.65 Later studies demonstrated that
the L mutation causes an increase in the incubation times.66
Few studies have been published involving moose (Alces
alces) and reindeer (Rangifer tarandus) due to the rarity of
naturally occurring cases of CWD in the wild.67 Among
moose variable sites have been identiﬁed at codon 36 (N-
asparagine or T-threonine),68 109 (K-lysine or Q-glutamine),
90 and 209 (M-methionine or I-isoleucine);69,70 however, it
is unclear what protective qualities these mutations may or
may not have for CWD infection. Mule deer and white-tailed
deer have been studied extensively, likely due to the higher
prevalence of CWD among these species.
Studies of the PRNP gene in mule deer and white-tailed
deer have identiﬁed a number of mutations both in the
amino acid and nucleotide sequences. Initial studies were
complicated by an unexpressed process pseudogene in some
but not all individuals.71 Further study of the pseudogene
did not reveal any effects on CWD infection in deer and the
presence of an asparagine mutation at codon 138 is absent
in the functional gene, thereby easily distinguishing the
two.72 The functional PRNP gene has been studied exten-
sively, notably two coding mutations have been identiﬁed in
the inferred amino acid sequence that has been linked to
reduced CWD susceptibility. Examination of allele frequen-
cies found few CWD-infected individuals with a substitu-
tion of histidine (H) for glutamine (Q) at codon 95
(aaQ95H) or a substitution of serine (S) for guanine (G) at
codon 96 (aaG96S).72,73 The effects of these mutations
were examined experimentally by orally infecting captive
white-tailed deer with known genotypes ﬁnding that these
mutations delay onset of CWD. Deer genotypes in this
study included wild type (aa95QQ/aa96GG, N=6), hetero-
zygous at aa95 only (aa95QH/aa96GG, N=1), aa96 only
(aa95QQ/aa96GS N=4) or heterozygous for both positions
(aa95QH/aa96GS, N=1).74 All deer presented with clinical
signs of CWD (with the exception of two deer euthanized
due to intercurrent disease); wild type genotypes having an
average incubation period of 693 (± 27) days, those with
only the aa96 mutations lasting 956 (± 107) days, and those
with only the aa95 or both aa95 and 96 mutation genotypes
succumbing to the disease after 1508 and 1596 days
(respectively).74
Examination of complete PRNP nucleotide sequence
corroborates these previous ﬁndings of CWD susceptibil-
ity and further the understanding of the role of this gene in
disease management. Kelly et al75 found ten polymorphic
sites in the PRNP gene from free roaming deer in Illinois
(N = 196 deer, 76 CWD-positives and 120 CWD-nega-
tive). This study identiﬁed both of the nonsynonymous
mutations (aa95 or nt285, and aa96 or nt286) conﬁrming
previous ﬁndings and identiﬁed three additional synon-
ymous mutations which were determined to be more com-
mon among deer testing negative for CWD. Similarly,
Wilson et al76 examined both white-tailed deer and mule
deer in Canada ﬁnding ﬁfteen variable sites among white-
tailed deer and two variable sites in mule deer. Of these
variable sites, only one nonsynonymous mutation (nt286)
and four synonymous mutations were determined to be
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associated with CWD susceptibility in white-tailed deer,76
and one nonsynonymous (nt59) and one synonymous
(nt393) mutation was identiﬁed in mule deer, each found
signiﬁcantly more often in mule deer testing negative for
CWD.76
When the combined effects of synonymous and nonsy-
nonymous mutations were considered from white-tailed
deer in Illinois and Wisconsin twenty-six unique haplotypes
were identiﬁed consisting of fourteen polymorphic sites (ten
previously reported75,76 and four novel).77,78 Two haplo-
types designated C and F were found less frequently
among deer testing positive for CWD. Each haplotype con-
tains one of the nonsynonymous mutations reported to
reduce CWD susceptibility as well as one synonymous
mutation. Haplotype C includes the nonsynonymous muta-
tion nt286A (aa96S) and one synonymous at nt555T, and
haplotype F contains the nonsynonymous mutation nt285C
(aa95H) and one synonymous at nt60T. Unlike scrapie, no
study has identiﬁed mutations that confer complete genetic
resistance to CWD. Brandt et al77 found that deer with
either the C or F haplotypes were less likely to be infected
with CWD but still detected positive deer possessing these
haplotypes.77,78 No studies have examined the protective
effects of these mutations with regard to infectious dose
of the prion protein.
The absence of complete genetic resistance to CWD
does not preclude the use of genetics as a tool to manage
the disease. Several studies analyzing white-tailed deer
landscape and population genetics in Wisconsin and
Illinois have led to a better understanding of deer movement
patterns and other dynamics that may inﬂuence the spread
of CWD. Deer were genotyped using microsatellite loci
ﬁnding that population structure was largely inﬂuenced by
female philopatry79 and landscape features can promote or
inhibit movement thus inﬂuencing disease spread.80–82 The
frequency of protective PRNP haplotypes may contribute to
population level susceptibility and shape the way CWD
spreads across the landscape. In Illinois where populations
have higher frequencies of the protective C or F haplotypes,
the geographic progression of the disease was slowed and
conﬁned to a smaller area.78 Control of CWD may require a
multifactorial approach where genetic proﬁles can assist in
the management of CWD.
Prevalence And Distribution
The origin of TSEs, and thus CWD, is not clear.
Speculative theories suggest that TSEs might have a spon-
taneous origin, however, these theories are not proven.83,84
Prevalence of CWD varies across North America, reaching
30% for free-ranging populations in endemic areas,53 but
can be, in unusual circumstances, as high as 80–90% in
captive populations.54 Initial endemic zones were limited
to northeastern Colorado and southeastern Wyoming, with
eventual growth to southeastern Wisconsin, extending east
to New York and West Virginia, and southward to New
Mexico.85,86 Since the ﬁrst report in captive mule deer in
Colorado nearly 50 years ago,1,54 CWD in North America
has spread to 26 US states and three provinces in Canada
(Saskatchewan, Alberta and Quebec; Figure 2).87 The ﬁrst
cases of CWD outside North America were reported by
the year 2000 in South Korea, after import of subclinical
CWD infected farmed elk from Canada.88,89 Recently,
CWD cases have been found in free-ranging reindeer and
moose in Norway, Finland and Sweden.67,87,90 CWD’s
expanding geographic distribution has been attributed to
both natural movements of free-ranging cervids, as well as
anthropogenic movement of infected farmed elk and deer.
Movement of animal carcasses and other animal bypro-
ducts that are known to be infectious under experimental
conditions—including natural cervid urine lures and antler
velvet—may be involved in facilitating the spread of
CWD.25,91
Since the initial report of CWD in mule deer
(Odocoileus hemionus) in a Colorado research facility in
the late 1960s,1 many captive and free-ranging cervid popu-
lations have been affected, and, by the time of writing this
paper, the known host of CWD has grown to include moose
(Alces alces), North American elk (Cervus canadensis and
Cervus elaphus elaphus, also known as wapiti), white-tailed
deer (Odocoileus Virginianus), red deer (Cervus elaphus),
sika deer (Cervus nipon), reindeer (Rangifer tarandus),
European moose (E. alces alces, also known as Eurasian
Elk), mule deer (Odocoileus hemionus) and subspecies
black-tailed deer (O. hemionus columbianus; Figure 3).92
Although the spread of CWD is well understood, no con-
clusive evidence to demonstrate a link between CWD in
North America and CWD in European cervids has been
established.67 This is mainly due to the lack of understand-
ing of the origins of CWD coupled with no evidence of
CWD in the cervid population in the European Union prior
to 2016,93 when the ﬁrst case of CWD in Europe was
discovered in a free-ranging Norwegian reindeer.91 Still,
prevalence of CWD in North America, Europe and possibly
other parts of the world is unknown.
Prevalence estimates are susceptible to the number of
deer tested, representing the occurrence of disease in the
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tested population in a geographic region at a particular
time. Based on hunter-harvested animal surveillance pro-
grams (1996–1999), CWD prevalence in an endemic area
in Colorado was estimated at approximately 5% in mule
deer, 2% in white-tailed deer and <1% in elk.52 By 2018,
CWD rates of infection were estimated to occur in about
one-third of Colorado’s elk population and about half of
the state’s deer population.94 In Wisconsin, CWD preva-
lence in white-tailed deer doubled in some areas during a
period of 6 years (2011–2016), with approximately 40–
50% adult males and 20–30% adult females infected.95
Despite reports of increasing rates of CWD in speciﬁc
locations in the US, surveillance data from other endemic
areas indicate that CWD prevalence rates have remained
low and changed little over long periods of time.96 This is
the case in Illinois, where surveillance and management
strategies were implemented and sustained since the ﬁrst
case of CWD was detected in 2002. Although prevalence
rates found in Illinois in 2018 were lower than previous
years, it was recognized that it is too early to suggest that
this trend will continue. Thus, long-term surveillance
and CWD management strategies need to continue to
slowdown the spread of disease and the increase in pre-
valence rates to parts of the state that remain CWD free.96
Prevalence is inﬂuenced by biotic factors, such as sex
and age, as well as abiotic factors associated to geographic
location (eg, soil and pH characteristic). Trends in preva-
lence in endemic areas in Wisconsin have increased during
the last 17 years, showing a rise in the prevalence from 8–
10% to over 35% in adult males and from 3–4% to over
15% in adult females at the western monitoring area;
during the same period of time the trends in prevalence
increased from 2% to 13% in male yearlings and from 2%
to 10% in yearling females.97 In Illinois, age and sex have
Figure 2 Reported distribution of Chronic Wasting Disease (CWD) in North America. By 2019, 26 states and 3 Canadian provinces have reported CWD cases in captive
and free-ranging cervid populations.
Notes: Credit to Bryan Richards, USGS National Wildlife Health Center (Public domain).160
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been found to be associated with differences in prevalence.
The mean prevalence rates during 2003–2018 have been
75% higher in males than in females;96 with higher rates in
adult deer (1.93%) than in yearlings (0.89%) and fawns
(0.45%); and higher rates of CWD in males than females,
although, in this study, sex difference was not signiﬁcant
(P=0.079).98 More recently, the overall CWD prevalence
in adult deer was estimated at 0.84% and was twice as
high in males (1.07%) compared to females (0.54%).96
Horizontal transmission is the most important route of
CWD infection52 and the most important contributing
factor for CWD prevalence and incidence. Miller et al41
demonstrated that naïve animals could contract CWD
when using sites where previous CWD-infected animals
were housed. Prions enter the environment via decaying
carcasses and excretion of bodily ﬂuids that have been
identiﬁed as containing high levels of PrPSC. Blood and
saliva are the biological ﬂuids with highest PrPSC levels,
followed by fecal matter and urine, thus carrying high
levels of infectivity. Other peripheral organs that accumu-
late large numbers of PrPSC include adrenal glands, thyr-
oid glands, lungs, liver, kidneys, bladder, pancreas,
gastrointestinal tract, retina, antler velvet, heart, tongue
and skeletal muscle.52 Prions from all these tissues can
enter the environment and remain infectious for long per-
iods of time.41,99,100 Soils and other fomites acting as
environmental reservoirs (eg, mineral licks) contribute to
horizontal transmission.101
Because of cervid grazing behaviors, infection can be
acquired via soil ingestion or soil inhalation, and by con-
tact with bioavailable PrPSC from biological material in
soil. It is not surprising that, because of this, much
research in recent years has focused on soil properties
(eg, organic matter, clay content, soil metals and soil pH)
and its contribution to PrPSC persistence in the
environment.98,100,102–109 For instance, attachment of the
prion proteins to minerals in clay may limit migration of
the infectious CWD protein through the soil column,
maintaining infectious PrPSC at the soil surface, contribut-
ing to CWD dissemination.103 While some of these soil
characteristics may inﬂuence PrPSC stability, persistence in
the environment and infectivity,100,104–106 others—such as
natural oxidants and soil humic acids—may interfere with
conversion of PrPC to the pathogenic PrPSC,107 or degrade
PrPSC and reduce CWD infectivity.108
Modeling studies based on CWD cases from surveil-
lance programs have evaluated landscape features related
to deer habitat and soil characteristics that could be
Figure 3 Chronological identiﬁcation of CWD in cervid species.
Notes: Data from Haley and Hoover (2015),54 Benestad and Telling (2018),52 Ricci et al (2017),67 Chronic Wasting disease Alliance.92
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environmental determinants for CWD risk, inﬂuencing
prion availability and persistence.98,109–111 Evaluation of
spatio-temporal patterns of CWD reported cases in white-
tailed deer at the border of Wisconsin and Illinois—one of
the hot spot areas for CWD in the US—found that land-
scape features such as larger and more compact forest, as
well as lower elevation areas closer to rivers, were asso-
ciated with higher risk of CWD; yet, other study found
areas with small forest patches increased the risk of CWD
occurrence.110 A geographical model focused on soil char-
acteristics and its contribution to CWD in free-ranging
deer found percent of clay and soil pH as the two most
important predictors of the persistent presence of CWD in
endemic areas.109 This is in agreement with ﬁndings by
O’Hara-Ruiz et al98 that indicated that less clay and more
sand enhance CWD persistence and transmission. Still,
while some studies agree that more clay is associated
with less CWD, others have found the opposite106 or no
association to CWD incidence.112
Beside soil, other common environmental materials
including wood, rocks, plastic, glass, cement, stainless
steel, aluminum and grass plants have been proven to
“bind, retain and release” prions.113,114 In the case of
plants, these can act as carriers of infection by binding
infectious prions from contaminated secretions, as well as
by uptake of prions from contaminated soils, and mobiliz-
ing them to aerial parts of the plants including steam and
leaves.113 After ﬁve decades of CWD research, many
factors that inﬂuence CWD prevalence have been identi-
ﬁed and several lines of evidence have expanded our
understanding of how CWD spreads in nature.
Nonetheless, many questions remain and signiﬁcant chal-
lenges need to be addressed in order to effectively control
CWD prevalence and reduce incidence at different geo-
graphic locations.
Impact
Chronic wasting disease has an ecologic, economic and
social effect, with deep impact on the viability of cervid
populations. An experimental study found a 60% decline in
full-term viable offspring born to CWD-positive muntjac
dams.48 Modeling studies have shown an annual population
decline of 10.4% in white-tailed deer and 21% in sympatric
mule deer populations in southeasternWyoming, corroborat-
ing the population-limiting impact of CWD.115,116 Survival
estimates indicate that CWD-infected mule deer were 4.5
more likely to die annually compared to CWD-negative
deer116 and were more susceptible to predation than
uninfected deer.117 The impact on elk populations in endemic
areas in Colorado and South Dakota has also shown declines
in survival118 and decrease in population growth rates.119
Conversely, the impact of CWD in low-density deer popula-
tions differs from places with high-density populations.Mule
deer living in arid San Andres Mountains—part of the
Chihuahuan Desert-range in southern New Mexico—
showed weak population effects based on CWD prevalence
and mortality data.120 Models reveal mixed results in long-
term survival of cervid populations based on observed epi-
demics in endemic areas of Wisconsin, Colorado and
Wyoming. Outcomes ranged from small host declines to
moderate epidemics, and in some cases, to complete host
extinction.121 Captive cervid facilities have been impacted by
CWD, with over 175 herd facilities affected across the US
and reported infection rates as high as 80% at some of these
facilities.122 The extent of disease impact in other parts of the
world is less understood. Because of the limited surveillance
across Europe—especially in remote areas—it is not possible
to exclude the possibility that CWD has been affecting cer-
vids across Europe for decades.91,93
Another consideration of the potential impact of CWD
is the risk to human health. Even though the only demon-
strated zoonotic TSE is variant Creutzfeldt–Jakob disease
(vCJD), which resulted from non-experimental transmis-
sion of classic bovine spongiform encephalopathy (BSE)
from cattle to humans,123 no absolute molecular barrier to
conversion of the human prion protein by the CWD prion
protein has been found.124 Experimental studies and epi-
demiological investigations, coupled with careful surveil-
lance, established a link between vCJD and BSE.
Nevertheless, ongoing surveillance and epidemiological
studies of humans living in CWD-endemic areas in
North America and Canada have not shown any increases
in human TSE cases,123,125 and have not been able to ﬁnd
associations between CWD and prion diseases in humans.
Laboratory and epidemiological data support the role of a
species barrier protecting humans from CWD.126–131
Experimental studies using humanized transgenic
mice did not result in CWD transmission,127 and
Raymond et al126 demonstrated a barrier at the molecular
level that appears to limit the susceptibility of humans,
cattle and sheep to CWD. Yet, susceptibility to CWD has
been shown in cattle, cats, sheep and goats under experi-
mental conditions following intracerebral inoculation.132
Oral inoculations, on the other hand, have been inefﬁ-
cient at inducing disease, suggesting a high species bar-
rier under oral exposure. Only recently oral inoculation
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was successful at inducing prion disease in squirrel mon-
keys and swine.130,131,133 In swine, the species barrier
was relatively high, as only low amount of prions was
found in brain and lymphoid tissue.133 Interestingly,
CWD has not been successfully transmitted to
Cynomolgus macaques, which are genetically closer to
humans than squirrel monkeys.129,131,134
More recently, the zoonotic potential of scrapie prions
was demonstrated after serial transmission of different
Scrapie isolates to humanized transgenic mice,135 coupled
with the reported transmission of Scrapie prions to pri-
mates after long incubation periods of 10 years.136 Taking
into account the long incubation periods—of a minimum
of 5 years—that was required before clinical disease was
observed after oral inoculation of Cynomolgus macaques
with BSE, surveillance and research should continue and
allow for long incubation periods to elucidate long-term
effect of CWD in nonhuman primates and potential con-
sequences to humans.
Beyond the direct impact of CWD on free-ranging
cervid populations and potential effect on human health,
there is an economic impact associated with management
of CWD, and the effect of CWD on hunters and farmed
cervid industry. For example, after the discovery and
spread of CWD in North America, an estimated $32.3
million was spent by Wisconsin for CWD surveillance
and management between 2001 and 2006.137 The potential
economic losses per farm have been estimated at
$290,000,138 and reached $53–$79 million in 2002 and
$45–$72 million in 2003 for hunters in Wisconsin.139
Total depopulation was required at some captive cervid
facilities, with costly government expenses associated with
compensation.95 According to the 2016 National Survey of
Fishing, Hunting, and Wildlife-Associated Recreation,140
an estimated 103 million Americans participated in ﬁsh-
ing, hunting or other wildlife-associated recreational activ-
ity, spending $156.9 billion on equipment, travel, licenses
and fees. Approximately 11.5 million were hunters, mean-
ing that 4% of the Americans 16 years of age or older
hunted in 2016. Revenues from hunting, ﬁshing and wild-
life-associated activities help to support wildlife and habi-
tat conservation efforts. However, concerns about the
potential and long-term impact of CWD to the cervid
captive and wildlife populations, compounded with
unknown risks of CWD transmission to humans, and evi-
dence of risk of transmission to swine, could impact these
revenues. CWD may reduce hunting and related activities
in endemic areas, affecting the cost of management disease
in areas where CWD becomes established. These, in turn,
could affect jobs and communities that depend on the
support of hunting and related activities across the nation.
Management Of CWD
Management guidelines for infectious diseases like CWD
are difﬁcult to develop and implement, as they need to
account for factors that inﬂuence prevalence, incidence,
transmission and geographic spread. Some of these factors
include population dynamics, genetics, animal movement
and dispersal, type of population (eg, captive or free-ran-
ging cervids) and landscape characteristics (eg, forest areas
or arid environments). Furthermore, the goals of proposed
management and control strategies of CWD should be
deﬁned according to disease status in different regions;
only then, strategies for control and/or prevention might
be implemented. While depopulation of an infected herd
followed by restocking after a period of 2 years is used for
farmed deer,141 management intervention strategies for free-
ranging populations are different; they consist of population
reduction—to minimize disease transmission—and selec-
tive culling of deer in CWD endemic areas—to control
CWD prevalence.142 These efforts require support from
hunters and landowners so that the management can be
applied. Eradication of CWD might not be realistic, but
control is; once CWD has become established, management
strategies should focus on limiting the growth of the num-
ber of infected individuals and therefore limit the increase
in prevalence.
Farmed cervid CWD management programs in the US
have been developed with the goal of creating a national
approach to control CWD incidence and prevent spread
between states. This is a collaborative effort among state
regulatory agencies (eg, wildlife and animal health agencies),
Animal and Plant Health Inspection Services (APHIS) and
owners of farmed cervid facilities. The USDA-APHIS CWD
management program includes a herd certiﬁcation program
that facilitates surveillance and interstate movement of non-
infected animals. The program provides guidance on fence
design, sampling strategies and response protocols if CWD is
detected in a facility (eg, quarantine and carcass disposal,
decontamination procedures and management of a herd dur-
ing the epidemiological investigation).143 Depending on the
epidemiological investigation, a herd could be classiﬁed as
(a) CWD-positive (if an animal tested positive for CWD), (b)
CWD-exposed (“if a CWD-positive animal resided in
another herd (or multiple herds) within the previous 5
years”) or (c) epidemiologically linked herds (all herds with
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animals that were in contact with other animals that pre-
viously resided with a CWD-positive animal). If a herd is
classiﬁed as CWD-positive or CWD-exposed, a quarantine
of 5 years should be issued—based on the date the herd was
last exposed to a CWD-positive animal—unless the herd is
depopulated.143
The four CWD management strategies used in North
American free-ranging wild deer include 1) general, non-
selective population harvest (spatially targeted); 2) selective
or targeted removal of clinical suspects (infected deer); 3)
seasonal harvest (eg, summer) and 4) vaccination.144
Predictive models that evaluated these management strate-
gies found that increased general hunting pressure with or
without targeted sex group, the role of large predators, and
seasonal hunting had some positive effect on CWD under
speciﬁc conditions.145–147 Yet, analytical experimental stu-
dies that included vaccination (eg, intramuscular vaccination
with two different prion peptide sequences) and oral admin-
istration of therapeutic compounds for prevention of CWD
infection showed ineffective results.148,149 A study evaluat-
ing the use of mucosal immunization with an attenuated
Salmonella vaccine expressing PrP found that the efﬁcacy
of the control measure was not clear.150 Two analytical
observational studies based on planned culling as the inter-
vention strategy found the control measure effective.144
Despite differences between intervention and control strate-
gies, studies that evaluated differences between government
culling and hunting, found that moderate but sustained inten-
sity with continued and frequent culling is needed to reduce
CWD prevalence.142 This effort minimizes the impact on
recreational deer harvest.151 Furthermore, other studies sug-
gested that management strategies focused on reducing
population prevalence instead of deer abundance are more
effective strategies in reducing CWD transmission.112
The objective of management and surveillance is to
protect the health of captive and free-ranging herds from
the spread of CWD, mitigate the negative consequences of
reduced recreational hunting on the economy, decrease the
geographic spread of CWD and reduce the potential of
CWD prions to be transmitted to the environment, humans
and any other species.98 Surveillance and monitoring of
CWD provide essential data that help with the develop-
ment of focused management strategies in endemic areas
and guide direct management efforts. Moreover, they help
with early detection of CWD, so timely dissemination of
information and necessary action can be taken.67 For
example, early detection of CWD in two captive herds
and two wild deer in New York in 2005 prompted
immediate actions that appear to have successfully miti-
gated CWD.152 However, for those regions where self-
sustaining CWD epizootics continue to be a challenge, as
in the state of Illinois, surveillance efforts have shown that
continued intensive management, focused on speciﬁc areas
infected with CWD, is a powerful management strategy
that helps to keep disease prevalence low.98 There are two
types of surveillance for CWD monitoring in free-ranging
cervid populations: passive surveillance (which include the
testing of road kills, dead, sick or suspect deer for CWD)
and active surveillance (which include testing of hunter-
harvested deer for CWD in target areas). Although knowl-
edge gaps in the epidemiology of CWD still exist, only
continued surveillance will inform CWD management and
control strategies.
Science-based policies will help to develop effective
management strategies that are relevant to the population
monitored. The development of long-term sustainable man-
agement strategies is necessary in order to keep low pre-
valence and to avoid dissemination of CWD. Left
unmanaged infection rates will affect the ability of cervidae
herds to sustain themselves.94 CWD regulations to prevent
further spread include restriction in translocation of captive
cervids and movement of hunter-killed big game carcasses,
high-risk tissues or bodily ﬂuids that tend to concentrate
high levels of PrPSC. Prion deposition in mineral licks was
demonstrated in an enzootic area in Wisconsin, corroborat-
ing the participation of mineral licks as risk factors for
CWD transmission, environmental reservoirs for CWD
prions and as potential sources for cross-species contamina-
tion as they attract livestock and non-cervid wildlife
species.101 The bans on baiting and feeding implemented
in multiple states in North America and municipalities in
Norway are crucial to reduce the congregation of animals
and to reduce direct contact rates of susceptible with
infected animals that in normal circumstances do not con-
gregate and feed on the precise same small area.153 This
regulatory ban helps to prevent direct transmission of infec-
tious diseases like tuberculosis, brucellosis and CWD.
Conclusions
Chronic wasting disease (CWD) is a highly contagious
prion disease that affects captive and free-ranging cervids.
The infectious agent is the misfolded prion protein
(PRPSC), which is primarily transmitted horizontally via
direct contact between animals or indirectly through con-
tact with infective secretions and contaminated fomites.
CWD is epizootic in the US and continues to expand
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through North America; outbreaks in Europe are on the
rise. Our current understanding of the long-term effect of
CWD on free-ranging populations is still limited.
However, we know the population-limiting impact of
CWD, even at low prevalence rates it affects the possibi-
lity of a herd to thrive. CWD is a 100% fatal slowly
progressive neurodegenerative disease, with long incuba-
tion periods wherein sub-clinical-infected animals contri-
bute to the shedding of the pathogenic PrPSC. Given the
longevity of infectious proteins in the environment and
that the disease is in a free-roaming population, managers
are unlikely to completely eliminate the disease, but they
can control it. Some management approaches have helped
sustain low CWD prevalence and slow the spread of the
disease. Genetic tools identify animal movement patterns
and population level susceptibility (ie, herd immunity),
helping to contain or reduced areas affected by CWD.
Yet, gaps in knowledge still exist. An improved under-
standing of population dynamics, deer behavior that inﬂu-
ence CWD transmission among free-ranging cervids and
prions in the environment is needed to facilitate CWD
management. The effect of protective haplotypes that
may be acting as a genetic barrier preventing the spread
of CWD, potential therapeutic strategies that will help to
protect and manage captive and free-ranging populations,
as well as new tools for effective antemortem detection,
environmental clean-up and prion protein degradation are
all integral components of the future management of
CWD. Regardless of the strategy, management of an infec-
tious disease such as CWD is a joint responsibility that
involves the government, state and local agencies, farmed
cervid producers, hunters and the general public. The key
to the success of CWD management in free-ranging deer
involves public acceptance and a continual support and
commitment to intervention. Only through ongoing scien-
tiﬁc research and management based on scientiﬁc evidence
can CWD be controlled. In the future, if a treatment or
cure is identiﬁed, our chances to take advantage of those
tools will be much better if CWD has been contained and
prevalence rates are low.
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